Francesco Parlati - 21 Jan 2022 Form 4 Insider Report for Calithera Biosciences, Inc.

Reporting relationship: SR. VP, RESEARCH
Issuer ticker: N/A
Reported as of: 21 Jan 2022
Net transaction value: -$2,356
SEC form: 4
Accepted by SEC: 25 Jan 2022, 15:05:49 UTC
Prior SEC filing: 06 Jan 2022
Next SEC filing: 27 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Francesco Parlati

Key filing fact

Francesco Parlati filed Form 4 for Calithera Biosciences, Inc. on 25 Jan 2022.

Key facts

This page summarizes Francesco Parlati's Form 4 filing for Calithera Biosciences, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Jan 2022, 15:05.

Change

Previous filing in this sequence was filed on 06 Jan 2022.
Current net transaction value: -$2,356.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CALA transaction

Common Stock

Tax liability

Transaction value: $2,356
Shares: -4,794
Change %: -3.3%
Price: $0.4915
Shares after: 140,998
Date: 21 Jan 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Footnote F2

The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 21, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.